| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.92▼ | 3.94▼ | 3.92▼ | 3.99▼ | 3.45▲ |
| MA10 | 3.92▼ | 3.91▼ | 3.85▲ | 3.68▲ | 3.77▲ |
| MA20 | 3.94▼ | 3.86▲ | 4.01▼ | 3.47▲ | 4.58▼ |
| MA50 | 3.92▼ | 4.06▼ | 3.85▲ | 3.78▲ | 5.13▼ |
| MA100 | 3.86▲ | 3.81▲ | 3.56▲ | 4.68▼ | 3.03▲ |
| MA200 | 4.00▼ | 3.53▲ | 3.48▲ | 5.36▼ | 3.19▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | 0.019▲ | -0.021▼ | 0.110▲ | -0.127▼ |
| RSI | 44.171▼ | 46.236▼ | 47.689▼ | 56.348▲ | 41.393▼ |
| STOCH | 33.120 | 84.103▲ | 62.491 | 72.103 | 18.979▼ |
| WILL %R | -68.421 | -23.636▲ | -64.103 | -48.276 | -66.869 |
| CCI | -112.095▼ | 41.518 | 3.191 | 61.843 | -6.023 |
|
Tuesday, November 03, 2026 11:00 PM
Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology and central nervous system conditions. Its lead candidates, NDV-01 and ...
|
|
Friday, October 30, 2026 09:12 AM
Medical device company ResMed (NYSE:RMD) in calendar Q3 2026 (fiscal Q1 2027), with sales up 5.9% year on year to $1.41 billion. Its non-GAAP profit of $2.91 per share was 8.9% above analysts’ ...
|
|
Thursday, October 29, 2026 01:53 PM
Medical device company ResMed (NYSE:RMD) announced in calendar Q3 2026 (fiscal Q1 2027), with revenue rising 5.9% year on year to $1.41 billion. Its non-GAAP profit of $2.91 per share was 8.9% above ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 3.81 | 3.97 | 3.69 | 3.90 | 1,055,411 |
| 05/11/26 | 4.325 | 4.325 | 3.685 | 3.77 | 1,486,557 |
| 04/11/26 | 4.34 | 4.60 | 4.11 | 4.17 | 2,635,237 |
| 03/11/26 | 3.88 | 4.31 | 3.88 | 4.27 | 2,664,747 |
| 02/11/26 | 3.61 | 3.93 | 3.595 | 3.84 | 2,256,995 |
| 30/10/26 | 3.42 | 3.655 | 3.30 | 3.58 | 1,413,755 |
| 29/10/26 | 3.38 | 3.485 | 3.29 | 3.44 | 1,610,447 |
| 28/10/26 | 3.21 | 3.36 | 3.18 | 3.35 | 1,614,702 |
| 27/10/26 | 3.22 | 3.33 | 3.175 | 3.21 | 1,673,658 |
| 26/10/26 | 3.30 | 3.305 | 3.215 | 3.23 | 775,832 |
|
|
||||
|
|
||||
|
|